Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers.
Bioengineered cell culture systems of central nervous system injury and disease.
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
Combination therapy in patients with relapsing-remitting multiple sclerosis (MS) CombiRx
Flupirtine as Oral Treatment in Multiple Sclerosis (FLORIMS)
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Preclinical studies of sex differences: a clinical perspective.
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Autoimmune myelopathies.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Ampyra (Fampyra)
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.

Pages